Daisuke Kotani, GI Medical oncologist, Chief physician at Department of Gastrointestinal Oncology at National Cancer Center Hospital East, Japan, shared a post on X:
“Oncology highlights in 11 clinical trials that will shape medicine in 2026
- Daraxonrasib for pancreatic cancer: An oral “molecular glue” targeting broad KRAS mutations
- Bria-IMT for breast cancer: Combining cell-based immunotherapy with ICI.”
More posts featuring Daisuke Kotani.
